RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Michelle Tallquist to Tamoxifen

This is a "connection" page, showing publications Michelle Tallquist has written about Tamoxifen.
Connection Strength

0.319
  1. Ruiz-Camp J, Rodr?guez-Castillo JA, Herold S, Mayer K, Vad?sz I, Tallquist MD, Seeger W, Ahlbrecht K, Morty RE. Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia. Transgenic Res. 2017 02; 26(1):165-170.
    View in: PubMed
    Score: 0.138
  2. Acharya A, Baek ST, Banfi S, Eskiocak B, Tallquist MD. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis. 2011 Nov; 49(11):870-7.
    View in: PubMed
    Score: 0.096
  3. Umbarkar P, Tousif S, Singh AP, Anderson JC, Zhang Q, Tallquist MD, Woodgett J, Lal H. Fibroblast GSK-3a Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Circ Res. 2022 09 16; 131(7):620-636.
    View in: PubMed
    Score: 0.052
  4. Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, Brody MJ, J Lin SC, Aronow BJ, Tallquist MD, Molkentin JD. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun. 2016 07 22; 7:12260.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support